Artia Global Partners LP — 13F holdings

Artia Global Partners LP reported 48 holdings worth $542M in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. ABVX ABIVAX SA — $68.8M (12.7%)
2. INSM INSMED INC — $62.8M (11.6%)
3. TRVI Trevi Therapeutics Inc — $41.2M (7.6%)
4. BTSG BRIGHTSPRING HEALTH SVCS INC — $36.1M (6.7%)
5. RVMD REVOLUTION Medicines Inc — $34.7M (6.4%)
6. ARGX ARGENX SE — $27.6M (5.1%)
7. ALKS Alkermes PLC — $23.5M (4.3%)
8. TVTX TRAVERE THERAPEUTICS INC — $19.3M (3.6%)
9. AZN ASTRAZENECA PLC — $18.7M (3.4%)
10. NAMS NEWAMSTERDAM PHARMA COMPANY — $17.1M (3.2%)